Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Chimerix Q4 EPS $(0.20) Beats $(0.24) Estimate, Sales $4.00K Miss $60.00K Estimate

Author: Benzinga Newsdesk | February 29, 2024 08:05am
Chimerix (NASDAQ:CMRX) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.24) by 16.67 percent. This is a 16.67 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $4.00 thousand which missed the analyst consensus estimate of $60.00 thousand by 93.33 percent. This is a 99.51 percent decrease over sales of $814.00 thousand the same period last year.

Posted In: CMRX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist